Hostname: page-component-7b7567c8c-tnzcf Total loading time: 0 Render date: 2026-11-12T15:37:01.288Z Has data issue: false hasContentIssue false

Costs and Outcomes of Pre-Operative Staphylococcus aureus Screening and Decolonization

Published online by Cambridge University Press:  23 June 2026

Jon (Wei Yong) Ong
Affiliation:
University of Minnesota
Susan Kline
Affiliation:
University of Minnesota

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Background: Staphylococcus aureus (SA) colonization affects about 30% of U.S. adults and increases surgical-site infection risk 2 - 10 fold. A prior study by Kline et al. (2018) laid the foundation for evaluating efficacy and cost effectiveness of pre-operative decolonization interventions. This study evaluates an expanded set of up-to-date interventions, including: Strategy 1 - Individuals screening positive for SA receive a 5-day, 3-drug bundle. Non-SA carriers receive 2 pre-operative chlorhexidine gluconate (CHG) showers. Strategy 2 - All individuals receive the 3-drug bundle for 5 days. Strategy 3 - All individuals receive day-of-surgery nasal povidone iodine plus 2 CHG showers. Strategy 4 - All individuals receive day-of-surgery nasal alcohol gel plus 2 CHG showers. The 3-drug bundle consists of daily CHG showers, twice-daily CHG mouth rinse, and twice-daily nasal mupirocin ointment for 5 days leading up to surgery. Methods: A decision analytic model (Figure 1) simulated a U.S. adult population undergoing elective surgery over a 150-day horizon to evaluate the impact of the four strategies on surgical-site infections, SSI-related deaths, and healthcare-associated costs. Model parameters (Table 1) were derived from Kline et al. (2018), supplemental literature, and expert opinion. The model was used to determine SSI cases and costs per 10,000 population. One-way and probabilistic sensitivity analyses were conducted to determine the impact of uncertainty on choice of strategy. Results: Results are summarized in Table 2 and Figure 2. Strategy 2: Treat-all with 3-drug bundle, had the lowest healthcare-associated costs and prevented the most SSI cases, followed successively by Strategies 1, 3 and 4. These findings were robust across a series of one-way sensitivity analysis; the model was most sensitive to SSI probability and the relative risk associated with S. aureus colonization, while treatment efficacy parameters demonstrated limited impact on the overall results. In probabilistic sensitivity analyses, in which multiple parameters were varied, Strategy 2 remained the optimal strategy, whereas Strategy 4 was identified as the most expensive and least effective strategy. Conclusion: The results of this cost effectiveness analysis, combined with the results of our recent survey showing decolonization strategies vary nationally, highlight an opportunity to improve decolonization practices and outcomes.

A flowchart illustrating decision analytical tree for treatment strategies.

A table listing parameters for a decision analytic model related to SSI, treatment efficacy, and cost.

A table comparing surgical site infection outcomes and costs for different decolonization strategies.

A scatter plot comparing strategies by number of surgical site infections (SSIs) versus deaths due to SSI, with bubble sizes indicating healthcare-associated costs (HCACs) per 10,000 population undergoing surgery.

Information

Type
SSI
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America